Cart, 0 Items

Subtotal (USD):$0.00
Your cart is empty
After you’ve made a selection, review it here before checking out.
Search titles
    Cover of Health Care Venture Capital Best Practices: Top Venture Capitals and CEOs On Company Growth Plans, Valuations, Exit Strategies, and Raising R

    Health Care Venture Capital Best Practices: Top Venture Capitals and CEOs On Company Growth Plans, Valuations, Exit Strategies, and Raising Rounds of Capital (Inside The Minds)

    Format
    Purchase option
    One-time purchase
    One-time purchase of this edition. Updates or new editions must be purchased separately.
    $125.00
    now
    Quantity
    Availability:
    In stock
    Softbound book - One-time purchase with no updates
    $125.00 USD
    now

    HEALTH CARE VENTURE CAPITAL BEST PRACTICES: TOP VCS AND CEOS ON COMPANY GROWTH PLANS, VALUATIONS, EXIT STRATEGIES, AND RAISING ROUNDS OF CAPITAL (INSIDE THE MINDS)

    Format

    Softbound book

    Purchase option

    One-time purchase with no updates

    Quantity

    1

    Total

    $125.00

    /now

    Product details
    Description

    This product provides an insider’s perspective on health care venture capital for venture capitalists, entrepreneurs, and industry executives. Topics include raising capital, establishing valuations, determining exit strategies, structuring deals, spotting

    Publisher:Aspatore
    Service Number:40729072
    Pages:92
    Publication date:2008-05-07
    Jurisdiction:General
    External Product Title:HEALTH CARE VENTURE CAPITAL BEST PRACTICES: TOP VCS AND CEOS ON COMPANY GROWTH PLANS, VALUATIONS, EXIT STRATEGIES, AND RAISING ROUNDS OF CAPITAL (INSIDE THE MINDS)
    Update frequency:As changes in the law dictate
    Update Format:N/A
    Available Formats:Softbound book
    Copyright:2008
    Shelf space:9
    Authors:

    Alex Zisson

    Alex Zisson joined Thomas, McNerney & Partners in 2002. Before that, he spent eleven years in the research department at Hambrecht & Quist and its successor firms, Chase H&Q and JPMorgan H&Q. During his tenure at H&Q, he led research 

    Jack W. Lasersohn

    Jack W. Lasersohn is a founding general partner of The Vertical Group, one of the largest venture capital firms in the United States focused on medical devices. The firm and its partners have founded or led investments in many of the most successful venture-backed 

    Kevin Hutchinson

    Kevin Hutchinson is a recognized expert and leader in health care information technology. He possesses deep expertise in interoperability, clinical transaction routing, automation of physician practice workflow, and the exchange of patient information 

    Philip Lee

    Philip Lee has held senior-level positions at high-tech software companies for more than two decades, including such well-known public companies as Oracle Corporation, Excelon Corporation, and Bolt, Beranek, Neumann. Eight of those years were spent as 

    Richard M. Ferrari

    Richard M. Ferrari has been a successful CEO of several medical technology companies, both prior to and after co-founding De Novo in 2000. Following De Novo’s investment in CryoVascular Systems, Mr. Ferrari became CEO, growing the initial five-person